《公司業績》京東健康(06618.HK)第三季非國際財務準則經營盈利逾6.5億人幣 按年增86.6%
京東健康(06618.HK)公布,今年第三季收入為105.2億元人民幣(下同),按年增長42.1%;錄經營盈利7,722.5萬元,扭轉去年同期的錄經營虧損5.56億元。按非國際財務報告準則計,經營盈利為6.55億元,按年增長86.6%。
京東健康指,第三季與國內外多家領先的醫療健康企業合作,以加快實物+服務連接及模式創新。京東健康與歐姆龍健康醫療達成戰略合作,雙方宣布將在服務模式創新及數智化營銷等多領域展開深入和合作,有效帶動用戶進行主動的健康管理。京東健康又與魚躍醫療將在C2M產品定制的基礎上,共同探索從家庭監測到院內護理的健康管理解決方案;並將在未來進一步打通「醫療器械+服務」多點聯接。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.